These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 35316802)

  • 1. Dosimetry in targeted alpha therapy. A systematic review: current findings and what is needed.
    Tronchin S; Forster JC; Hickson K; Bezak E
    Phys Med Biol; 2022 Apr; 67(9):. PubMed ID: 35316802
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeted alpha therapy: part I.
    Elgqvist J
    Curr Radiopharm; 2011 Jul; 4(3):176. PubMed ID: 22201706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted alpha therapy: a critical review of translational dosimetry research with emphasis on actinium-225.
    Castillo Seoane D; de Saint-Hubert M; Crabbe M; Struelens L; Koole M
    Q J Nucl Med Mol Imaging; 2020 Sep; 64(3):265-277. PubMed ID: 32441067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy.
    Lee D; Li M; Bednarz B; Schultz MK
    Radiat Res; 2018 Sep; 190(3):236-247. PubMed ID: 29944461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microdosimetry for targeted alpha therapy of cancer.
    Huang CY; Guatelli S; Oborn BM; Allen BJ
    Comput Math Methods Med; 2012; 2012():153212. PubMed ID: 22988479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling the effect of daughter migration on dosimetry estimates for unlabeled actinium-225.
    Tronchin S; Forster J; Hickson K; Bezak E
    Med Phys; 2024 Jul; 51(7):5032-5044. PubMed ID: 38197481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid-tumor radionuclide therapy dosimetry: new paradigms in view of tumor microenvironment and angiogenesis.
    Zhu X; Palmer MR; Makrigiorgos GM; Kassis AI
    Med Phys; 2010 Jun; 37(6):2974-84. PubMed ID: 20632610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular dose conversion factors for alpha-particle--emitting radionuclides of interest in radionuclide therapy.
    Hamacher KA; Den RB; Den EI; Sgouros G
    J Nucl Med; 2001 Aug; 42(8):1216-21. PubMed ID: 11483682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a transmission alpha particle dosimetry technique using A549 cells and a Ra-223 source for targeted alpha therapy.
    Al Darwish R; Staudacher AH; Li Y; Brown MP; Bezak E
    Med Phys; 2016 Nov; 43(11):6145. PubMed ID: 27806616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radionuclide spatial distribution and dose deposition for in vitro assessments of
    Frelin-Labalme AM; Roger T; Falzone N; Quan Lee B; Sibson NR; Vallis KA; Bernaudin M; Valable S; Corroyer-Dulmont A
    Med Phys; 2020 Mar; 47(3):1317-1326. PubMed ID: 31838744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Targeted Alpha Particle Therapy for Solid Tumors.
    Tafreshi NK; Doligalski ML; Tichacek CJ; Pandya DN; Budzevich MM; El-Haddad G; Khushalani NI; Moros EG; McLaughlin ML; Wadas TJ; Morse DL
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31779154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-particle microdosimetry.
    Chouin N; Bardies M
    Curr Radiopharm; 2011 Jul; 4(3):266-80. PubMed ID: 22201713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Monte Carlo Investigation of Dose Point Kernel Scaling for α-Emitting Radionuclides.
    Khan AU; DeWerd LA
    Cancer Biother Radiopharm; 2021 Apr; 36(3):252-259. PubMed ID: 33337280
    [No Abstract]   [Full Text] [Related]  

  • 14. Monte Carlo dosimetry of a realistic multicellular model of follicular lymphoma in a context of radioimmunotherapy.
    Bordes J; Incerti S; Mora-Ramirez E; Tranel J; Rossi C; Bezombes C; Bordenave J; Bardiès M; Brown R; Bordage MC
    Med Phys; 2020 Oct; 47(10):5222-5234. PubMed ID: 32623743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Effect of Chelating Arms and Carrier Agents on t he Radiotoxicity of TAT Agents.
    Farzipour S; Shaghaghi Z; Raeispour M; Alvandi M; Jalali F; Yazdi A
    Curr Radiopharm; 2023; 16(1):2-22. PubMed ID: 35538822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nephron-based model of the kidneys for macro-to-micro α-particle dosimetry.
    Hobbs RF; Song H; Huso DL; Sundel MH; Sgouros G
    Phys Med Biol; 2012 Jul; 57(13):4403-24. PubMed ID: 22705986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Internal microdosimetry of alpha-emitting radionuclides.
    Hofmann W; Li WB; Friedland W; Miller BW; Madas B; Bardiès M; Balásházy I
    Radiat Environ Biophys; 2020 Mar; 59(1):29-62. PubMed ID: 31863162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between Targeted Radionuclide Therapy of Bone Metastases Based on β-Emitting and α-Emitting Radionuclides.
    Sadremomtaz A; Masoumi M
    J Med Imaging Radiat Sci; 2019 Jun; 50(2):272-279. PubMed ID: 31176435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetry and Radiobiology of Alpha-Particle Emitting Radionuclides.
    Sgouros G; Hobbs R; Josefsson A
    Curr Radiopharm; 2018; 11(3):209-214. PubMed ID: 29697036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technical Note: The development of a multi-physics simulation tool to estimate the background dose by systemic targeted alpha therapy.
    Xu T; Liu T; Li G; Dugal C; Aydemir NA; Liu Y; Roeske JC
    Med Phys; 2020 Jun; 47(6):2550-2557. PubMed ID: 32129888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.